All Posts Tagged Tag: ‘cancer treatment’

Breakthrough in Melanoma Treatment Research

Funded by the National Cancer Institute, The Wistar Institute recently released a finding in their research on treating metastatic melanoma. Melanoma is a form of skin cancer that can be found anywhere on the body. Metastatic melanoma spreads to areas of the body other than the site of the original tumor. While usually not life threatening when discovered and treated …

Read More

U.S. Death Rate From Cancer is Dropping Fast

Though cancer hasn’t been completely cured, it’s clear that treatments for the disease have improved over the past two decades. A yearly report from the American Cancer Society has shown that the death rate from cancer in the U.S. is declining among all Americans and for the most common types of cancer. The report, published recently in the Journal of …

Read More

Cancer Treatment Could Come From Link to Childhood Leukemia

A new study led by St. Jude Children’s Research Hospital could lead to a new treatment of certain types of childhood leukemia. The study, published in the journal Nature Genetics, has found a genetic basis for two leukemia subtypes seen in children. While normal human cells have 46 chromosomes, the high-risk leukemia called hypodiploid acute lymphoblastic leukemia (ALL) has fewer …

Read More

Cancer Survivors Urged to Make Sperm Bank Follow-ups

New research presented at the Fertility 2013 conference this week in Liverpool, England shows that many male cancer patients are not getting sufficient advice about their future fertility. Though sperm banking is often recommended for men diagnosed with cancer, many of them do not follow up with fertility advice. In the case of men in the U.K., this could mean …

Read More

Cancer Research Identifies New Potential Breast Cancer Driver

A new study has moved forward with a drug that could target a newly-identified breast cancer driver. Breast cancers are defined and treated according to their hormonal drivers, of which the most common are estrogen, progesterone, and HER2. Androgen receptors have now been targeted as a potential driver of so-called triple negative breast cancers. The new clinical trial has demonstrated …

Read More

Cancer Treatment Kevetrin Begins Clinical Trials

Today the Cellceutix Corporation announced that its new anti-cancer drug candidate Kevetrin will soon be entering clinical trials at the Harvard Cancer Center’s Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center. Cellceutix is a biopharmaceutical company focused on small molecule drugs for the treatment of “unmet” medical conditions, such as drug-resistant cancers and autoimmune diseases. Kevetrin is Cellceutix’s name …

Read More

Cancer Treatment Gets A Boost From Genomic Supercomputing

Dr. Patrick Soon-Shiong, Chairman of NantHealth and the Chan Soon-Shiong Institute for Advanced Health, as well as the most wealthy American in Los Angeles according to Forbes, this week announced the launch of the fastest genomic supercomputing platform in the U.S. Soon-Shiong states that the technology will reduce the time needed for cancer genome analysis from eight weeks to only …

Read More

Cancer Treatment for Colorectal Cancer Approved

The U.S. Food and Drug Administration (FDA) this week announced that it has approved a new drug for the treatment of colorectal cancer. According to the U.S. Centers for Disease Control and Prevention (CDC), colorectal cancer is the third most common cancer for both men and women, and the third leading cause of cancer deaths in the U.S. The drug …

Read More

Herceptin Breast Cancer Drug Shown to Greatly Increase Heart Risks

A study by the Group Health Research Institute in Seattle has determined that trastuzumab, the drug behind the brand name Herceptin, raises the risks for heart problems in breast cancer patients much more than previously thought. Trastuzumab is widely prescribed alongside chemotherapy to increase survival chances for patients with breast cancer. Erin Bowles, an epidemiologist at the Group Health Research …

Read More

Cancer Drug Erbitux Fails to Produce Results in Trials

The cancer drug Erbitux, which is manufactured by Merck & Co., Inc, has failed to produce any significant new results for the second month in a row. The German pharmaceutical company, one of the largest in the world, watched helplessly as their wonder drug crashed and burned, ultimately failing in its quest to increase the life span of those patients …

Read More

Israel Invents Weed Without The Stoner Effect

Israeli scientists have cultivated a Marijuana plant that doesn’t get people high when they smoke it. No, it is not some form of inhumane torture, it’s an effort to deliver the medicinal soothing effects of marijuana to patients struggling with various diseases, while not exposing them to the disorienting high often associated with smoking the substance. While some may believe …

Read More